Results 171 to 180 of about 159,586 (333)

Supplementary Table 1 from Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte–Derived HLA-Ligandome Using a Reverse Immunology Approach

, 2023
Pleun Hombrink, Cesare Hassan, Michel G.D. Kester, Lorenz Jahn, Margot J. Pont, Arnoud H. de Ru, Cornelis A.M. van Bergen, Marieke Griffioen, J.H. Frederik Falkenburg, Peter A. van Veelen, Mirjam H.M. Heemskerk   +10 more
openalex   +1 more source

RORγt‐APCs: The New Masters of Oral Tolerance

Barrier Immunity, EarlyView.
ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley   +1 more source

High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.

, 1994
Yuri Sykulev, Anders Brunmark, Theodore J. Tsomides, Shigeki Kageyama, Michael R. Jackson, P A Peterson, Herman N. Eisen   +6 more
openalex   +2 more sources

Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cells [PDF]

, 1994
Nathalia A. Giese, Thomas Giese, Herbert C. Morse   +2 more
openalex   +1 more source

Rutaceae Zanthoxylum–Derived 7‐Demethylsuberosin Alleviates the Rheumatoid Arthritis Through Inhibiting the Maturation of Dendritic Cells via Targeting MAPK14 Functional Food‐Based 7‐Demethylsuberosin

Food Frontiers, EarlyView.
This study revealed that 7‐demethylsuberosin exhibits immunosuppressive effects both in vivo and in vitro. Furthermore, it inhibits the phosphorylation of MAPK14 by targeting it, thereby modulating dendritic cell (DC) maturation and function and reducing inflammation across various in vivo models.
Peng Han, Bo Wang, Luyang Han, Yanbo Zhu, Jiawei Dong, Yuekang Xu, Xiaoying Liu, Jinyao Li   +7 more
wiley   +1 more source

Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.

, 1993
Sergey Apasov, M V Sitkovsky
openalex   +2 more sources

Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group. [PDF]

, 1988
W Mcdonald, C Jersild, T Fog, G Hansen, M Thomsen, A Svejgaard, B Dupont, L Stendahl-Brodin, H Link, E Moller, E Norrby, N Raun, T Fog, A Heltberg, P Platz, J Mertin, P Rudge, M Kremer, C Poser, D Paty, L Scheinberg, J Kurtzke, P Terasaki, J Mcclelland, M Madigand, Jj-F Oger, R Fauchet, Sabouraud, B Genetet, D Francis, J Batchelor, W Mcdonald, Jec Hern, A Downie, R Swingler, Das Compston, S Poser, G Ritter, H Bauer, H Gross-Wilde, E Kumert, N Raun, R Collins, L Espinoza, C Plank, G Ebers, R Rosenberg, J Zabriskie, L Dejaegher, M De Bruyere, P Ketelaer, H Carton, O Hommes, Kjb Lamers, P Reekers   +54 more
openalex   +1 more source

Advanced extracellular vesicle immunotherapy

FlexMat, EarlyView.
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang, Yunfei Mu, Xianyue Ji, Xiaoting Jiang, Ruiheng Wang, Xianguang Ding, Lianhui Wang   +6 more
wiley   +1 more source

Characterization and evolution of MHC II genes in the European eel (Anguilla anguilla) [PDF]

, 2013
Bracamonte, Seraina E.
core  

Foreign H-2-like ,olecules on a murine tumor (MCG4) [PDF]

, 1980
Garcia-Olivares, E., Garrido, F., Hübsch, D., Koszinowski, Ulrich H., Schirrmacher, V.   +4 more
core   +1 more source